Document Detail

Translation initiation factor eIF-4G is immunogenic, overexpressed, and amplified in patients with squamous cell lung carcinoma.
MedLine Citation:
PMID:  11550153     Owner:  NLM     Status:  MEDLINE    
BACKGROUND: Recently, the authors reported identification and cloning of several novel immunogenic antigens in squamous cell lung carcinoma. Of 14 corresponding genes, 9 mapped in an amplified chromosomal region with the gene for eIF-4G that was amplified most frequently. METHODS: Recombinant eIF-4G was expressed in E. coli and screened with sera from patients with squamous cell carcinoma of the lung and of the head and neck. Protein extracts from squamous cell carcinoma tissues were analyzed for eIF-4G expression by Western blot analysis. Mutation analysis was performed using an automatic DNA sequencer. RESULTS: The authors screened a spectrum of 33 heterologous sera from lung carcinoma patients and detected antibodies against eIF-4G in 5 of these sera (15%). They found no immune response to eIF-4G in 17 sera from squamous cell carcinoma tissues derived from the head and neck. In addition, no antibodies were found to eIF-4G in a group of 17 control sera from individuals without known tumor formation. Sequence analysis of the eIF-4G gave no indication of mutations. To analyze the expression of eIF-4G, a monoclonal antibody was used. Western blot analysis clearly showed overexpression in the tumor tissue compared with the corresponding normal lung tissues. CONCLUSIONS: The translation initiation factor eIF-4G is the first protein in which the gene shows amplification, has increased expression in a human tumor, and induces an immune response in patients. eIF-4G lends itself as a marker for the diagnosis of and possibly as a future therapeutic target in patients with squamous cell lung carcinoma.
C Bauer; I Diesinger; N Brass; H Steinhart; H Iro; E U Meese
Related Documents :
618573 - Transplacental lung tumorigenesis in the athymic mouse.
12231503 - Bleomycin sensitivity of mice expressing dominant-negative p53 in the lung epithelium.
894743 - Prevention by splenectomy of thymus weight depletion in the presence of progressively g...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Cancer     Volume:  92     ISSN:  0008-543X     ISO Abbreviation:  Cancer     Publication Date:  2001 Aug 
Date Detail:
Created Date:  2001-09-10     Completed Date:  2001-09-20     Revised Date:  2006-04-21    
Medline Journal Info:
Nlm Unique ID:  0374236     Medline TA:  Cancer     Country:  United States    
Other Details:
Languages:  eng     Pagination:  822-9     Citation Subset:  AIM; IM    
Copyright Information:
Copyright 2001 American Cancer Society.
Department of Human Genetics, Medical School, University of Saarland, 66421 Homburg/Saar, Germany.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Antibody Formation
Antigens, Neoplasm
Blotting, Western
Carcinoma, Squamous Cell / diagnosis,  genetics*,  metabolism
DNA / isolation & purification
DNA, Complementary
Eukaryotic Initiation Factor-4G
Gene Amplification
Genetic Markers
Genetic Vectors
Lung Neoplasms / diagnosis,  genetics*,  metabolism
Peptide Initiation Factors* / genetics,  immunology
Protein Biosynthesis
Reg. No./Substance:
0/Antigens, Neoplasm; 0/DNA, Complementary; 0/Eukaryotic Initiation Factor-4G; 0/Genetic Markers; 0/Peptide Initiation Factors; 9007-49-2/DNA

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Ifosfamide, cisplatin, and 13-Cis retinoic acid for patients with advanced or recurrent squamous cel...
Next Document:  Flexible chemotherapy regimen with gemcitabine and vinorelbine for metastatic nonsmall cell lung car...